Metformin has attracted intense interest in longevity research due to consistent evidence of lifespan extension in animal studies and epidemiological data showing metformin users live longer than non-diabetic controls.
Cellular aging mechanisms:
- Activates AMPK, the cellular energy sensor that promotes autophagy (cellular cleanup)
- Reduces inflammation and oxidative stress
- Improves mitochondrial function
- May slow biological aging at the epigenetic level
Disease prevention: Research suggests metformin reduces risk of cardiovascular disease, certain cancers, Alzheimer’s disease and cognitive decline, and age-related metabolic dysfunction.
Healthspan extension: Beyond lifespan, metformin appears to extend healthspan – the years you remain physically and cognitively functional. It’s not about living longer while sick. It’s about maintaining vitality.
Many high performers use metformin as foundational longevity optimization, even without diabetes or weight loss goals. The TAME trial (Targeting Aging with Metformin) is currently investigating its effects on aging in non-diabetic populations.